Evidence map›Paper›PMID 30452458›Full record

ArticlePLoS genetics2018

Deleterious mitochondrial DNA point mutations are overrepresented in Drosophila expressing a proofreading-defective DNA polymerase γ.

Colby L Samstag, Jake G Hoekstra, Chiu-Hui Huang, Mark J Chaisson, Richard J Youle, Scott R Kennedy, Leo J Pallanck

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. MtDNA deletions and aging.Frontiers in aging · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Mitigation of age-dependent accumulation of defective mitochondrial genomes.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Colby L SamstagMolecular and Cellular Biology Program, University of Washington, Seattle, WA, United States of America.ORCID 0000-0002-5491-7725
Jake G HoekstraDepartment of Pathology, University of Washington, Seattle, WA, United States of America.
Chiu-Hui HuangSurgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.ORCID 0000-0003-1485-5731
Mark J ChaissonComputational Biology and Bioinformatics, University of Southern California, Los Angeles, CA, United States of America.
Richard J YouleSurgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.
Scott R KennedyDepartment of Pathology, University of Washington, Seattle, WA, United States of America.ORCID 0000-0002-4444-1145
Leo J PallanckDepartment of Genome Sciences, University of Washington, Seattle, WA, United States of America.ORCID 0000-0002-5943-9339
University of Washington · USNational Institutes of Health · USUniversity of Southern California · US

Funding

Role of mitochondria in neurodegenerative diseasesZIANS003123 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI YOULE, RICHARD JAMES · 2011 to 2025
$28.8M
INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
Genetic Analysis of the PINK1-Parkin PathwayR01GM104990 · NIGMS · UNIVERSITY OF WASHINGTON · PI PALLANCK, LEO J · 2013 to 2016
$1.2M
Mechanisms of somatic mtDNA mutation detection and eliminationR21NS090073 · NINDS · UNIVERSITY OF WASHINGTON · PI PALLANCK, LEO J · 2014 to 2015
$425k
NHGRI NIH HHS T32 HG000035NIA NIH HHS T32 AG000057NIGMS NIH HHS R01 GM104990NINDS NIH HHS R21 NS090073
6 · The paper itself

Abstract

Mitochondrial DNA (mtDNA) mutations cause severe maternally inherited syndromes and the accumulation of somatic mtDNA mutations is implicated in aging and common diseases. However, the mechanisms that influence the frequency and pathogenicity of mtDNA mutations are poorly understood. To address this matter, we created a Drosophila mtDNA mutator strain expressing a proofreading-deficient form of the mitochondrial DNA polymerase. Mutator flies have a dramatically increased somatic mtDNA mutation frequency that correlates with the dosage of the proofreading-deficient polymerase. Mutator flies also exhibit mitochondrial dysfunction, shortened lifespan, a progressive locomotor deficit, and loss of dopaminergic neurons. Surprisingly, the frequency of nonsynonymous, pathogenic, and conserved-site mutations in mutator flies exceeded predictions of a neutral mutational model, indicating the existence of a positive selection mechanism that favors deleterious mtDNA variants. We propose from these findings that deleterious mtDNA mutations are overrepresented because they selectively evade quality control surveillance or because they are amplified through compensatory mitochondrial biogenesis.

Indexed as

Point MutationAgingAnimalsAnimals, Genetically ModifiedDNA, MitochondrialDNA Polymerase gammaDNA ReplicationDopaminergic NeuronsDrosophila melanogasterDrosophila ProteinsGenes, InsectLongevityMitochondriaMotor ActivityOrganelle BiogenesisDNA, MitochondrialDNA Polymerase gammaDrosophila Proteins

Identifiers

PMID30452458
PMCPMC6289449
OpenAlexW2901585995

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.